nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—TNF—metabolic syndrome X	0.761	1	CbGaD
Pranlukast—CYSLTR1—Signaling by GPCR—AGT—metabolic syndrome X	6.8e-05	0.000284	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—AKT1—metabolic syndrome X	6.74e-05	0.000282	CbGpPWpGaD
Pranlukast—TNF—Toll-like Receptor Signaling Pathway—IL6—metabolic syndrome X	6.73e-05	0.000281	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CD36—metabolic syndrome X	6.71e-05	0.00028	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—LEP—metabolic syndrome X	6.7e-05	0.00028	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CCL5—metabolic syndrome X	6.69e-05	0.000279	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CYBA—metabolic syndrome X	6.68e-05	0.000279	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—PLA2G4A—metabolic syndrome X	6.67e-05	0.000278	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	6.63e-05	0.000277	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—LPL—metabolic syndrome X	6.54e-05	0.000273	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—GHRL—metabolic syndrome X	6.54e-05	0.000273	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CD36—metabolic syndrome X	6.44e-05	0.000269	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—AKT1—metabolic syndrome X	6.36e-05	0.000266	CbGpPWpGaD
Pranlukast—NFKB1—Myometrial Relaxation and Contraction Pathways—IL6—metabolic syndrome X	6.32e-05	0.000264	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—IL6—metabolic syndrome X	6.29e-05	0.000263	CbGpPWpGaD
Pranlukast—ABCC2—NRF2 pathway—TGFB1—metabolic syndrome X	6.25e-05	0.000261	CbGpPWpGaD
Pranlukast—TNF—Toll-like Receptor Signaling Pathway—AKT1—metabolic syndrome X	6.21e-05	0.000259	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CNR1—metabolic syndrome X	6.2e-05	0.000259	CbGpPWpGaD
Pranlukast—NFKB1—BDNF signaling pathway—AKT1—metabolic syndrome X	6.19e-05	0.000258	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	6.15e-05	0.000257	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—LPL—metabolic syndrome X	6.09e-05	0.000254	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CRP—metabolic syndrome X	6.05e-05	0.000252	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—TGFB1—metabolic syndrome X	5.99e-05	0.00025	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—IL6—metabolic syndrome X	5.99e-05	0.00025	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—AKT1—metabolic syndrome X	5.96e-05	0.000249	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CYBA—metabolic syndrome X	5.85e-05	0.000244	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—PPARG—metabolic syndrome X	5.84e-05	0.000244	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—CD36—metabolic syndrome X	5.79e-05	0.000242	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—INS—metabolic syndrome X	5.72e-05	0.000239	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—FABP4—metabolic syndrome X	5.7e-05	0.000238	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—IL6—metabolic syndrome X	5.69e-05	0.000237	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HDAC3—metabolic syndrome X	5.61e-05	0.000234	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—CCL2—metabolic syndrome X	5.6e-05	0.000234	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—AGT—metabolic syndrome X	5.6e-05	0.000234	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—AKT1—metabolic syndrome X	5.57e-05	0.000233	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—IL6—metabolic syndrome X	5.54e-05	0.000231	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—AKT1—metabolic syndrome X	5.49e-05	0.000229	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—LEP—metabolic syndrome X	5.48e-05	0.000229	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—APOE—metabolic syndrome X	5.48e-05	0.000229	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—AKT1—metabolic syndrome X	5.47e-05	0.000228	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—IL6—metabolic syndrome X	5.46e-05	0.000228	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—APOA1—metabolic syndrome X	5.42e-05	0.000226	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—metabolic syndrome X	5.41e-05	0.000226	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—HSD11B1—metabolic syndrome X	5.4e-05	0.000226	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—PPARA—metabolic syndrome X	5.38e-05	0.000225	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—IRS1—metabolic syndrome X	5.28e-05	0.00022	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—IL6—metabolic syndrome X	5.26e-05	0.000219	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—AKT1—metabolic syndrome X	5.24e-05	0.000219	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—LEP—metabolic syndrome X	5.1e-05	0.000213	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—IRS1—metabolic syndrome X	5.07e-05	0.000212	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IGF2—metabolic syndrome X	5.07e-05	0.000211	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—APOB—metabolic syndrome X	5.05e-05	0.000211	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MTNR1B—metabolic syndrome X	5.02e-05	0.000209	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	4.94e-05	0.000206	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—APOB—metabolic syndrome X	4.92e-05	0.000205	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IRS1—metabolic syndrome X	4.89e-05	0.000204	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TRIB3—metabolic syndrome X	4.89e-05	0.000204	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—RBP4—metabolic syndrome X	4.89e-05	0.000204	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—AKT1—metabolic syndrome X	4.85e-05	0.000203	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—AKT1—metabolic syndrome X	4.85e-05	0.000202	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CCL5—metabolic syndrome X	4.8e-05	0.0002	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—IL6—metabolic syndrome X	4.79e-05	0.0002	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PLA2G4A—metabolic syndrome X	4.78e-05	0.0002	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—VCAM1—metabolic syndrome X	4.75e-05	0.000199	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—GGT1—metabolic syndrome X	4.72e-05	0.000197	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—HDAC3—metabolic syndrome X	4.7e-05	0.000196	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—LPL—metabolic syndrome X	4.7e-05	0.000196	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—INS—metabolic syndrome X	4.68e-05	0.000196	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CCL2—metabolic syndrome X	4.61e-05	0.000192	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—LPA—metabolic syndrome X	4.6e-05	0.000192	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IGF1—metabolic syndrome X	4.53e-05	0.000189	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—metabolic syndrome X	4.45e-05	0.000186	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—PPARG—metabolic syndrome X	4.45e-05	0.000186	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—AKT1—metabolic syndrome X	4.44e-05	0.000186	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—APOA5—metabolic syndrome X	4.41e-05	0.000184	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—INS—metabolic syndrome X	4.36e-05	0.000182	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—APOC3—metabolic syndrome X	4.33e-05	0.000181	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—SERPINE1—metabolic syndrome X	4.3e-05	0.00018	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	4.26e-05	0.000178	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL18—metabolic syndrome X	4.21e-05	0.000176	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—AKT1—metabolic syndrome X	4.17e-05	0.000174	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—IL6—metabolic syndrome X	4.13e-05	0.000172	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NOS3—metabolic syndrome X	4.11e-05	0.000172	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—TRIB3—metabolic syndrome X	4.1e-05	0.000171	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—AGT—metabolic syndrome X	4.02e-05	0.000168	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	4e-05	0.000167	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IL6—metabolic syndrome X	3.94e-05	0.000164	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—LEP—metabolic syndrome X	3.94e-05	0.000164	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—APOE—metabolic syndrome X	3.94e-05	0.000164	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HTR2C—metabolic syndrome X	3.91e-05	0.000163	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CD36—metabolic syndrome X	3.91e-05	0.000163	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—APOA1—metabolic syndrome X	3.89e-05	0.000162	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—IL6—metabolic syndrome X	3.87e-05	0.000162	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CYBA—metabolic syndrome X	3.78e-05	0.000158	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	3.76e-05	0.000157	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—GHRL—metabolic syndrome X	3.7e-05	0.000155	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—metabolic syndrome X	3.65e-05	0.000152	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—metabolic syndrome X	3.63e-05	0.000151	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—AKT1—metabolic syndrome X	3.57e-05	0.000149	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—FMO3—metabolic syndrome X	3.56e-05	0.000149	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CRP—metabolic syndrome X	3.52e-05	0.000147	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—CETP—metabolic syndrome X	3.52e-05	0.000147	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—AKT1—metabolic syndrome X	3.52e-05	0.000147	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IRS1—metabolic syndrome X	3.51e-05	0.000147	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CNR1—metabolic syndrome X	3.51e-05	0.000146	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—IL6—metabolic syndrome X	3.47e-05	0.000145	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	3.37e-05	0.000141	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—INS—metabolic syndrome X	3.36e-05	0.00014	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—TGFB1—metabolic syndrome X	3.32e-05	0.000139	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CCL2—metabolic syndrome X	3.31e-05	0.000138	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	3.27e-05	0.000137	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IGF1—metabolic syndrome X	3.25e-05	0.000136	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—AKT1—metabolic syndrome X	3.2e-05	0.000133	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	3.19e-05	0.000133	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—MLXIPL—metabolic syndrome X	3.18e-05	0.000133	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—EPHX2—metabolic syndrome X	3.18e-05	0.000133	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL6—metabolic syndrome X	3.17e-05	0.000132	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—ALB—metabolic syndrome X	3.17e-05	0.000132	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—TNF—metabolic syndrome X	3.1e-05	0.000129	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—SERPINE1—metabolic syndrome X	3.09e-05	0.000129	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IRS1—metabolic syndrome X	3.07e-05	0.000128	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—G6PC2—metabolic syndrome X	2.99e-05	0.000125	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NOS3—metabolic syndrome X	2.95e-05	0.000123	CbGpPWpGaD
Pranlukast—IL5—Immune System—AKT1—metabolic syndrome X	2.92e-05	0.000122	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IGF2—metabolic syndrome X	2.87e-05	0.00012	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	2.84e-05	0.000119	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—APOB—metabolic syndrome X	2.78e-05	0.000116	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	2.75e-05	0.000115	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCL5—metabolic syndrome X	2.72e-05	0.000114	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TGFB1—metabolic syndrome X	2.72e-05	0.000113	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PLA2G4A—metabolic syndrome X	2.71e-05	0.000113	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—LPL—metabolic syndrome X	2.66e-05	0.000111	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—FABP4—metabolic syndrome X	2.54e-05	0.000106	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—TGFB1—metabolic syndrome X	2.53e-05	0.000106	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—AKT1—metabolic syndrome X	2.53e-05	0.000105	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—IL6—metabolic syndrome X	2.5e-05	0.000104	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—IL6—metabolic syndrome X	2.49e-05	0.000104	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—HSD11B1—metabolic syndrome X	2.41e-05	0.0001	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—FMO3—metabolic syndrome X	2.35e-05	9.81e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	2.33e-05	9.74e-05	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—AKT1—metabolic syndrome X	2.31e-05	9.63e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—AKT1—metabolic syndrome X	2.29e-05	9.58e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—AGT—metabolic syndrome X	2.27e-05	9.5e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	2.27e-05	9.48e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—LEP—metabolic syndrome X	2.23e-05	9.3e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—APOE—metabolic syndrome X	2.23e-05	9.3e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	2.23e-05	9.3e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—IL6—metabolic syndrome X	2.21e-05	9.22e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—APOA1—metabolic syndrome X	2.2e-05	9.2e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—G6PD—metabolic syndrome X	2.15e-05	8.96e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	2.12e-05	8.84e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—MLXIPL—metabolic syndrome X	2.09e-05	8.74e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—EPHX2—metabolic syndrome X	2.09e-05	8.74e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—HDAC3—metabolic syndrome X	2.09e-05	8.74e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IL6—metabolic syndrome X	2.05e-05	8.55e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GCKR—metabolic syndrome X	2.05e-05	8.54e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—LPA—metabolic syndrome X	2.05e-05	8.54e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—AKT1—metabolic syndrome X	2.04e-05	8.51e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IRS1—metabolic syndrome X	1.99e-05	8.3e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PLA2G6—metabolic syndrome X	1.98e-05	8.27e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—G6PC2—metabolic syndrome X	1.97e-05	8.22e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	1.97e-05	8.22e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—APOA5—metabolic syndrome X	1.96e-05	8.19e-05	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—AKT1—metabolic syndrome X	1.96e-05	8.17e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TGFB1—metabolic syndrome X	1.95e-05	8.14e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	1.91e-05	7.96e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—IL6—metabolic syndrome X	1.91e-05	7.96e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—INS—metabolic syndrome X	1.9e-05	7.95e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—AKT1—metabolic syndrome X	1.89e-05	7.88e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCL2—metabolic syndrome X	1.87e-05	7.82e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	1.87e-05	7.8e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	1.85e-05	7.71e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IGF1—metabolic syndrome X	1.84e-05	7.69e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—TRIB3—metabolic syndrome X	1.82e-05	7.62e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—AKT1—metabolic syndrome X	1.76e-05	7.34e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SERPINE1—metabolic syndrome X	1.75e-05	7.3e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—FABP4—metabolic syndrome X	1.67e-05	6.99e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NOS3—metabolic syndrome X	1.67e-05	6.97e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—NAMPT—metabolic syndrome X	1.64e-05	6.83e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	1.63e-05	6.79e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—LIPC—metabolic syndrome X	1.63e-05	6.79e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GCK—metabolic syndrome X	1.63e-05	6.79e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—APOC3—metabolic syndrome X	1.62e-05	6.75e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—HSD11B1—metabolic syndrome X	1.59e-05	6.63e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CETP—metabolic syndrome X	1.57e-05	6.55e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SCARB1—metabolic syndrome X	1.5e-05	6.27e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IL6—metabolic syndrome X	1.47e-05	6.13e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	1.46e-05	6.11e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SREBF1—metabolic syndrome X	1.46e-05	6.09e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—HMGCR—metabolic syndrome X	1.42e-05	5.92e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GOT2—metabolic syndrome X	1.42e-05	5.92e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—G6PD—metabolic syndrome X	1.41e-05	5.91e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	1.38e-05	5.77e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—AKT1—metabolic syndrome X	1.36e-05	5.66e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GCKR—metabolic syndrome X	1.35e-05	5.63e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—LPA—metabolic syndrome X	1.35e-05	5.63e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	1.31e-05	5.46e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—APOA5—metabolic syndrome X	1.29e-05	5.4e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL6—metabolic syndrome X	1.29e-05	5.37e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	1.28e-05	5.34e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ABCA1—metabolic syndrome X	1.26e-05	5.28e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SLC2A4—metabolic syndrome X	1.26e-05	5.28e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GGT1—metabolic syndrome X	1.22e-05	5.11e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GOT1—metabolic syndrome X	1.22e-05	5.11e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	1.2e-05	5.02e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—AKT1—metabolic syndrome X	1.19e-05	4.96e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TGFB1—metabolic syndrome X	1.1e-05	4.61e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	1.08e-05	4.5e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—LIPC—metabolic syndrome X	1.07e-05	4.48e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GCK—metabolic syndrome X	1.07e-05	4.48e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—APOC3—metabolic syndrome X	1.07e-05	4.45e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—APOB—metabolic syndrome X	1.04e-05	4.34e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CETP—metabolic syndrome X	1.03e-05	4.32e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PLA2G4A—metabolic syndrome X	1.01e-05	4.22e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—LPL—metabolic syndrome X	9.92e-06	4.14e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	9.91e-06	4.14e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	9.62e-06	4.02e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CD36—metabolic syndrome X	9.43e-06	3.94e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	9.35e-06	3.91e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GOT2—metabolic syndrome X	9.35e-06	3.91e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PPARA—metabolic syndrome X	8.76e-06	3.66e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—AGT—metabolic syndrome X	8.49e-06	3.54e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	8.34e-06	3.48e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	8.34e-06	3.48e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IL6—metabolic syndrome X	8.32e-06	3.47e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—APOE—metabolic syndrome X	8.32e-06	3.47e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—APOA1—metabolic syndrome X	8.22e-06	3.43e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GOT1—metabolic syndrome X	8.08e-06	3.37e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GGT1—metabolic syndrome X	8.08e-06	3.37e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—AKT1—metabolic syndrome X	7.67e-06	3.2e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PPARG—metabolic syndrome X	7.24e-06	3.02e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—INS—metabolic syndrome X	7.1e-06	2.97e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—APOB—metabolic syndrome X	6.85e-06	2.86e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	6.67e-06	2.78e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—LPL—metabolic syndrome X	6.54e-06	2.73e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ALB—metabolic syndrome X	6.51e-06	2.72e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—NOS3—metabolic syndrome X	6.23e-06	2.6e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CD36—metabolic syndrome X	6.22e-06	2.6e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PPARA—metabolic syndrome X	5.78e-06	2.41e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PTGS2—metabolic syndrome X	5.7e-06	2.38e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—AGT—metabolic syndrome X	5.6e-06	2.34e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—APOE—metabolic syndrome X	5.48e-06	2.29e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—APOA1—metabolic syndrome X	5.42e-06	2.26e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PPARG—metabolic syndrome X	4.78e-06	1.99e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—INS—metabolic syndrome X	4.69e-06	1.96e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ALB—metabolic syndrome X	4.3e-06	1.79e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—NOS3—metabolic syndrome X	4.11e-06	1.72e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	3.76e-06	1.57e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—AKT1—metabolic syndrome X	2.86e-06	1.2e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—AKT1—metabolic syndrome X	1.89e-06	7.89e-06	CbGpPWpGaD
